PDL BIOPHARMA, INC. (PDLI) has 31 open-market insider trades by 18 insiders since 2006. The most active filer is David W. Gryska, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Silver Point Capital L.P. via Robert J. O'Shea | 10% Owner | — | 3 | $36.5M | 2021-02-01 |
| Robert J. O'Shea | 10% Owner | — | 2 | $7.1M | 2020-12-29 |
| Edward A. Mule | 10% Owner | — | 1 | $4.5M | 2020-12-17 |
| John Peter McLaughlin | Dir | — | 1 | $1.6M | 2020-12-22 |
| Dominique Monnet | CEOPres | — | 1 | $1.3M | 2020-12-16 |
| David W. Gryska | Dir | — | 5 | $1.1M | 2020-12-30 |
| Christopher Lewis Stone | VPSecretary | — | 1 | $512K | 2020-12-16 |
| Laurence Jay Korn | Dir | — | 1 | $457K | 2006-11-29 |
| Elizabeth G. O'Farrell | Dir | — | 2 | $427K | 2020-11-23 |
| Peter S. Garcia | PresCFO | — | 4 | $268K | 2018-12-27 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Silver Point Capital L.P. | 10% Owner | Buy | $767K | 2021-02-01 |
| David W. Gryska | Director | Sell | $110K | 2020-12-30 |
| Silver Point Capital L.P. | 10% Owner | Buy | $31.6M | 2020-12-30 |
| Robert J. O'Shea | 10% Owner | Buy | $1.7M | 2020-12-24 |
| John Peter McLaughlin | Director | Sell | $1.6M | 2020-12-21 |
| Silver Point Capital L.P. | 10% Owner | Buy | $4.1M |
Companies that share insiders with PDLI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2020-12-21 |
| Dominique Monnet | CEO & President | Sell | $1.3M | 2020-12-16 |
| Christopher Lewis Stone | VP & Secretary | Sell | $512K | 2020-12-16 |
| David W. Gryska | Director | Sell | $201K | 2020-12-16 |
| Edward A. Mule | 10% Owner | Buy | $4.5M | 2020-12-16 |
| Robert J. O'Shea | 10% Owner | Buy | $5.4M | 2020-12-11 |
| David W. Gryska | Director | Sell | $189K | 2020-12-03 |
| David W. Gryska | Director | Sell | $243K | 2020-11-23 |
| Elizabeth G. O'Farrell | Director | Sell | $126K | 2020-11-23 |
| Alan Lee Bazaar | Director | Sell | $162K | 2020-11-20 |